President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...

U.S. hospitals and generic drugmakers are urging President Trump to exempt medical goods from new tariffs on Chinese imports, ...

Big Pharma is downplaying — for now — the potential negative impacts of President Donald Trump’s China tariffs on their industry. Merck (MRK) chief financial officer Caroline Litchfield told ...

Q4 2024 Management View CEO Stephan Tanda highlighted that Aptar achieved 2% core sales growth in Q4 2024 and delivered adjusted EPS of $1.52, exceeding the top end of guidance due to ...